Your browser doesn't support javascript.
loading
Prevention and Rehabilitation After Heart Transplantation: A Clinical Consensus Statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a Section of ESOT.
Simonenko, Maria; Hansen, Dominique; Niebauer, Josef; Volterrani, Maurizio; Adamopoulos, Stamatis; Amarelli, Cristiano; Ambrosetti, Marco; Anker, Stefan D; Bayes-Genis, Antonio; Ben Gal, Tuvia; Bowen, T Scott; Cacciatore, Francesco; Caminiti, Giuseppe; Cavarretta, Elena; Chioncel, Ovidiu; Coats, Andrew J S; Cohen-Solal, Alain; D'Ascenzi, Flavio; de Pablo Zarzosa, Carmen; Gevaert, Andreas B; Gustafsson, Finn; Kemps, Hareld; Hill, Loreena; Jaarsma, Tiny; Jankowska, Ewa; Joyce, Emer; Krankel, Nicolle; Lainscak, Mitja; Lund, Lars H; Moura, Brenda; Nytrøen, Kari; Osto, Elena; Piepoli, Massimo; Potena, Luciano; Rakisheva, Amina; Rosano, Giuseppe; Savarese, Gianluigi; Seferovic, Petar M; Thompson, David R; Thum, Thomas; Van Craenenbroeck, Emeline M.
Afiliação
  • Simonenko M; Cardiopulmonary Exercise Test Research Department, Heart Transplantation Outpatient Department, V. A. Almazov National Medical Research Centre, St. Petersburg, Russia.
  • Hansen D; REVAL and BIOMED Rehabilitation Research Center, Hasselt University, Hasselt, Belgium.
  • Niebauer J; Heart Centre Hasselt, Jessa Hospital, Hasselt, Belgium.
  • Volterrani M; University Institute of Sports Medicine, Prevention and Rehabilitation, Paracelsus Medical University, Salzburg, Austria.
  • Adamopoulos S; Cardio-Pulmonary Department, IRCCS San Raffaele Roma, Rome, Italy.
  • Amarelli C; Heart Failure and Heart Transplantation Unit, Onassis Cardiac Surgery Center, Athens, Greece.
  • Ambrosetti M; Department of Cardiac Surgery and Transplants, Monaldi Hospital, Azienda dei Colli, Naples, Italy.
  • Anker SD; Cardiovascular Rehabilitation Unit, ASST Crema, Santa Marta Hospital, Rivolta D'Adda, Italy.
  • Bayes-Genis A; Department of Cardiology (CVK), Berlin Institute of Health Center for Regenerative Therapies (BCRT), German Centre for Cardiovascular Research (DZHK) Partner Site Berlin, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Ben Gal T; University Hospital Germans Trias and Pujol de Badalona, Badalona, Spain.
  • Bowen TS; Heart Failure Unit, Cardiology Department, Rabin Medical Center, Petah Tikva and Sackler, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Cacciatore F; School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom.
  • Caminiti G; Department of Translational Medicine, University of Naples "Federico II", Naples, Italy.
  • Cavarretta E; Cardio-Pulmonary Department, IRCCS San Raffaele Roma, Rome, Italy.
  • Chioncel O; Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Rome, Italy.
  • Coats AJS; Mediterranea Cardiocentro, Naples, Italy.
  • Cohen-Solal A; Emergency Institute for Cardiovascular Diseases "Prof. C. C. Iliescu", Bucharest, Romania.
  • D'Ascenzi F; University of Medicine Carol Davila, Bucharest, Romania.
  • de Pablo Zarzosa C; Heart Research Institute, Sydney, NSW, Australia.
  • Gevaert AB; Cardiology Department, University of Paris, INSERM UMRS-942, Hopital Lariboisiere, AP-HP, Paris, France.
  • Gustafsson F; Division of Cardiology, Department of Medical Biotechnologies, University of Siena, Siena, Italy.
  • Kemps H; Department of Cardiology, Ramón y Cajal University Hospital, Madrid, Spain.
  • Hill L; Research Group Cardiovascular Diseases, Genetics, Pharmacology and Physiopathology of Heart, Blood Vessels and Skeleton (GENCOR) Department, University of Antwerp, Antwerp, Belgium.
  • Jaarsma T; Department of Cardiology, Antwerp University Hospital, Edegem, Belgium.
  • Jankowska E; Department of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Joyce E; Department of Cardiology, Maxima Medical Centre, Eindhoven, Netherlands.
  • Krankel N; Department of Industrial Design, Eindhoven University of Technology, Eindhoven, Netherlands.
  • Lainscak M; School of Nursing and Midwifery, Queen's University Belfast, Belfast, United Kingdom.
  • Lund LH; Department of Health, Medicine and Caring Science, Linköping University, Linköping, Sweden.
  • Moura B; Julius Center, University Medical Center Utrecht, Utrecht, Netherlands.
  • Nytrøen K; Department of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland.
  • Osto E; Department of Cardiology, Mater University Hospital, Dublin, Ireland.
  • Piepoli M; School of Medicine, University College Dublin, Dublin, Ireland.
  • Potena L; Universitätsmedizin Berlin Campus Benjamin Franklin Klinik für Kardiologie Charite, Berlin, Germany.
  • Rakisheva A; General Hospital Murska Sobota, Murska Sobota, Slovenia.
  • Rosano G; Department of Medicine, Karolinska Institutet and Heart and Vascular Theme, Karolinska University Hospital, Stockholm, Sweden.
  • Savarese G; Armed Forces Hospital, Porto, Portugal.
  • Seferovic PM; Centre for Health Technologies and Services Research, Faculty of Medicine of University of Porto, Porto, Portugal.
  • Thompson DR; Department of Cardiology, Oslo University Hospital Rikshospitalet, Oslo, Norway.
  • Thum T; Division of Physiology and Pathophysiology, Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Medical University of Graz, Graz, Austria.
  • Van Craenenbroeck EM; Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
Transpl Int ; 37: 13191, 2024.
Article em En | MEDLINE | ID: mdl-39015154
ABSTRACT
Little is known either about either physical activity patterns, or other lifestyle-related prevention measures in heart transplantation (HTx) recipients. The history of HTx started more than 50 years ago but there are still no guidelines or position papers highlighting the features of prevention and rehabilitation after HTx. The aims of this scientific statement are (i) to explain the importance of prevention and rehabilitation after HTx, and (ii) to promote the factors (modifiable/non-modifiable) that should be addressed after HTx to improve patients' physical capacity, quality of life and survival. All HTx team members have their role to play in the care of these patients and multidisciplinary prevention and rehabilitation programmes designed for transplant recipients. HTx recipients are clearly not healthy disease-free subjects yet they also significantly differ from heart failure patients or those who are supported with mechanical circulatory support. Therefore, prevention and rehabilitation after HTx both need to be specifically tailored to this patient population and be multidisciplinary in nature. Prevention and rehabilitation programmes should be initiated early after HTx and continued during the entire post-transplant journey. This clinical consensus statement focuses on the importance and the characteristics of prevention and rehabilitation designed for HTx recipients.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Transplante de Coração / Insuficiência Cardíaca Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Transplante de Coração / Insuficiência Cardíaca Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2024 Tipo de documento: Article